Mutations in the hemochromatosis gene (HFE) and stroke

Area of Science:

• Genetics and Cardiovascular Disease
• Iron Metabolism and Stroke Risk

Background:

• Elevated serum iron is a known risk factor for stroke.
• HFE gene mutations (C282Y, H63D) are associated with increased serum iron levels.
• Potential link between HFE mutations, iron levels, and stroke risk warrants investigation.

Purpose of the Study:

• To investigate the association between HFE gene mutations (C282Y, H63D) and stroke.
• To examine the relationship between HFE mutations, carotid atherosclerosis, and stroke.
• To explore the influence of HFE mutations on the interplay of hypertension, smoking, and stroke.

Main Methods:

• Compared HFE C282Y and H63D mutation frequencies in 202 stroke cases versus 2730 controls (Rotterdam Study).
• Utilized logistic regression to analyze HFE mutation influence on hypertension, smoking, and stroke relationships.
• Assessed mean carotid artery intima-media thickness in relation to hypertension, smoking, and HFE genotype in non-stroke subjects.

Main Results:

• No significant difference in HFE C282Y/H63D carrier rates between stroke cases (43.7%) and controls (37.6%).
• HFE carriers with hypertension showed an odds ratio of 3.0 for stroke; smokers had an odds ratio of 2.6.
• HFE carriers who smoked or were hypertensive exhibited increased carotid artery intima-media thickness compared to non-carriers.

Conclusions:

• HFE gene mutations are not significantly associated with stroke or carotid atherosclerosis.
• The HFE gene may play a modifying role in the relationship between smoking and stroke.
• Further research is needed to elucidate the complex interactions between HFE genotype, iron metabolism, and cardiovascular events.